Medical News

RSS

New anti-inflammatory strategy for cancer therapy

A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system’s inflammatory response into a cancer-killing outcome, is suggested in research findings by investigators at the University of California, San Diego (UCSD) School of Medicine.

20 Sep 2004

Imperative that strategies to control tuberculosis include measures to treat individuals with MDR disease

Challenging the notion that multidrug-resistant tuberculosis (MDR-TB) poses a low threat to populations, epidemiologists at the Harvard School of Public Health (HSPH) have constructed a mathematical model of the disease variant's potential course

20 Sep 2004

New computer program helps health departments halt outbreaks

Imagine that a terrorist has just released the smallpox virus in Atlanta, and suddenly there’s a race against time to vaccinate and treat every last man, woman and child in metro Atlanta before the deadly virus can spread.

20 Sep 2004

FDA proposed new egg safety regulations to reduce Salmonella Enteritidis cases

When implemented, the production changes defined by the regulation will significantly reduce the number of illness caused by eggs contaminated with Salmonella Enteritidis.

20 Sep 2004

Research may provide a better understanding of the mental retardation observed in Cri-du-Chat Syndrome

By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.

20 Sep 2004

Scientists decipher genetic code of ancient pathogen that causes the horse disease

More than 2,400 years after Hippocrates, the Greek physician born in 460 BC first described the symptoms of glanders, scientists have deciphered the genetic code of the ancient pathogen that causes the horse disease: Burkholderia mallei.

20 Sep 2004

Link between elevated blood sugar levels in diabetics and increased risk of life-threatening forms of cardiovascular disease

A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.

20 Sep 2004

Vanilla may become a drug to treat sickle cell disease

In addition to its popular role in flavoring ice cream, fudge and cake frosting, vanilla may have a future use as a medicine. Recent laboratory research has strengthened the possibility that a form of vanilla may become a drug to treat sickle cell disease.

20 Sep 2004

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

An intriguing link between a mother’s stress levels during pregnancy and the effect on the brain of her unborn baby is revealed in a new study of children born in Bristol, England.

20 Sep 2004

Discovery of dopamine terminal injury in brains of people with HIV dementia

Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have discovered a key mechanism in the brains of people with human immunodeficiency virus (HIV) dementia.

20 Sep 2004

Scientists unlock the crucial communication pathways of p53 protein cells

Professor Nicholas La Thangue and his team at the Institute of Biomedical and Life Sciences at the University of Glasgow have unlocked the crucial communication pathways of p53 protein cells, which could ultimate aid the slowing down of cells that cause tumours and related disease.

20 Sep 2004

Investigation into the potential for designing drug treatments based on a person’s genetic makeup

Most current drugs are not effective for 100 per cent of the population and some work in as few as 30 to 50 per cent of cases. Pharmacogenetics, the study of how genetic factors influence a person’s response to a drug, is seen as a way of making treatments as safe and effective as possible for every individual.

20 Sep 2004

Disabled people need better specialist equipment

For many disabled people, assistive technology is crucial to their ability to choose how they want to live and whether they can live independently.

20 Sep 2004

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

Australia’s leading health advisory body, the National Health and Medical Research Council, says there should be a five-year moratorium on any clinical research into animal-to-human whole organ transplants in Australia.

20 Sep 2004

Global health is recurrently being threatened by new and re-emerging infectious diseases

Global health is recurrently being threatened by new and re-emerging infectious diseases. Examples of new and re-emerging infectious diseases include SARS (Severe Acute Respiratory Syndrome), new variant CJD (Creutzfeldt-Jakob Disease), avian flu and Ebola.

20 Sep 2004

Study shows high levels of body dissatisfaction and unhealthy weight-control behaviours among contemporary black South African females

Black South African women have once more been flagged up as being on the brink of an eating disorder crisis, as the latest research reveals that their male counterparts, who once idolised fuller-figured females, now prefer thinner, Western-looking women.

20 Sep 2004

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Cytogen Corporation today announced the presentation of new data relating to its lead therapeutic product Quadramet (samarium Sm-153 lexidronam injection) during the 36th Congress of the International Society of Pediatric Oncology (SIOP).

20 Sep 2004

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Isis Pharmaceuticals announced today that Eli Lilly and Company licensed LY2275796, a second-generation antisense anti-cancer drug candidate for clinical development.

20 Sep 2004

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.

20 Sep 2004

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche announced today that results from a randomized Phase III clinical study of the investigational drug Tarceva (erlotinib HCl), in combination with gemcitabine chemotherapy met its primary endpoint of improving survival.

20 Sep 2004

Medical News

New anti-inflammatory strategy for cancer therapy

Imperative that strategies to control tuberculosis include measures to treat individuals with MDR disease

New computer program helps health departments halt outbreaks

FDA proposed new egg safety regulations to reduce Salmonella Enteritidis cases

Research may provide a better understanding of the mental retardation observed in Cri-du-Chat Syndrome

Scientists decipher genetic code of ancient pathogen that causes the horse disease

Link between elevated blood sugar levels in diabetics and increased risk of life-threatening forms of cardiovascular disease

Vanilla may become a drug to treat sickle cell disease

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

Discovery of dopamine terminal injury in brains of people with HIV dementia

Scientists unlock the crucial communication pathways of p53 protein cells

Investigation into the potential for designing drug treatments based on a person’s genetic makeup

Disabled people need better specialist equipment

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

Global health is recurrently being threatened by new and re-emerging infectious diseases

Study shows high levels of body dissatisfaction and unhealthy weight-control behaviours among contemporary black South African females

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News